FDA Inspection
VitalantVitalant – FDA Inspection, Jun 16, 2017
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on June 16, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Person
- Sandra Sejdinovic (Issuing Officer)
View Company Profile
ID · e1e28767-7bdf-4f53-913e-abf8f40429cf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1017789
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Vitalant
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 23, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 4, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 22, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 23, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 7, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1277087 - 2025-07-23
- FDA Inspection 1205605 - 2023-05-04
- FDA Inspection 1081616 - 2019-02-22
- FDA Inspection 936053 - 2015-07-23
- FDA Inspection 831898 - 2013-05-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.